Uterine vascular function in a transgenic preeclampsia rat model

Area of Science:

• Reproductive Biology
• Cardiovascular Physiology
• Endocrinology

Background:

• Preeclampsia is a pregnancy complication associated with endothelial dysfunction and intrauterine growth restriction.
• The renin-angiotensin system plays a crucial role in blood pressure regulation and its activation is implicated in preeclampsia pathogenesis.
• Understanding the interplay between the renin-angiotensin system, endothelial function, and placental development is vital for managing preeclampsia.

Purpose of the Study:

• To investigate intrauterine growth restriction, endothelial function, and uterine artery blood flow in a transgenic preeclampsia rat model with an activated renin-angiotensin system.
• To compare these parameters in preeclamptic Sprague-Dawley (SD-PE) rats with normal pregnant and nonpregnant Sprague-Dawley rats.
• To elucidate the role of the renin-angiotensin system and prostanoid balance in preeclampsia-induced vascular dysfunction.

Main Methods:

• Utilized a transgenic preeclampsia rat model (SD-PE) with an activated renin-angiotensin system.
• Employed transabdominal ultrasound to assess fetal growth and uterine artery blood flow (Doppler resistance index).
• Performed isolated uterine artery studies to evaluate contractile and relaxant responses to vasoactive agents (phenylephrine, acetylcholine) and assessed serum prostacyclin and thromboxane levels.

Main Results:

• SD-PE rat embryos exhibited intrauterine growth restriction.
• Uterine arteries from SD-PE rats showed impaired vasorelaxation to acetylcholine, suggesting endothelial dysfunction.
• A decreased serum prostacyclin (6-keto-prostaglandin F1alpha):thromboxane ratio was observed in SD-PE rats.
• Surprisingly, the Doppler resistance index in uterine arteries was decreased in SD-PE rats, indicating unimpaired uteroplacental flow despite altered endothelial function.

Conclusions:

• Activation of the renin-angiotensin system in this rat model induces preeclampsia-like features, including intrauterine growth restriction and endothelial dysfunction.
• Despite endothelial dysfunction, uteroplacental blood flow appears maintained, suggesting compensatory mechanisms.
• A disturbed prostacyclin:thromboxane ratio may be a significant mediator in the development of endothelial dysfunction in this preeclampsia model.